Restenosis following percutaneous revascularization - The potential role of thrombin and the thrombin receptor

Annals of Hematology, Supplement

Volumn 73, Issue 1, 1996, Pages

  Stouffer, G A ^a   Schmedtje, J F ^a   Gulba, D ^a   Huber, K ^a   Bode, C ^a   Aaron, J ^a   Runge, M S ^a,b  

^a University of Texas Medical Branch School of Medicine   (United States)

^b John Sealy Hospital and John Sealy Annex   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY; INTEGRIN; SERINE PROTEINASE; THROMBIN; THROMBIN RECEPTOR;

ATHEROSCLEROTIC PLAQUE; CORONARY ARTERY OBSTRUCTION; HEART MUSCLE ISCHEMIA; HUMAN; PRIORITY JOURNAL; RESTENOSIS; REVASCULARIZATION; SHORT SURVEY; STENT; TRANSLUMINAL CORONARY ANGIOPLASTY;

ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; ANIMALS; CONSTRICTION, PATHOLOGIC; CORONARY DISEASE; HUMANS; RECEPTORS, THROMBIN; THROMBIN;

EID: 0029790563     PISSN: 09458077     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Short Survey

References (14)

1. Serruys PW, de Jaegere P, Kiemeneij F, Macaya C, Rutsch W, Heyndrickx G, Emanuelsson H, Marco J, Legrand V, Materne P, et al (1994) A comparison of balloon-expandable-stent implantation with balloon angioplasty in patients with coronary artery disease. Benestent Study Group. N Engl J Med 331:489-495
2. Topol EJ, et al (1994) Randomised trial of coronary intervention with antibody against platelet IIb/IIIa integrin for reduction of clinical restenosis: results at six months. Lancet 343:881-886
3. Ip JH, Fuster V, Israel D, Badimon L, Badimon J, Chesebro JH (1991) The role of platelets, thrombin and hyperplasia in restenosis after coronary angioplasty. J Am Coll Cardiol 17: 77B-88B
4. Nelken NA, Soifer SJ, O'Keefe J, Vu T-K, Charo IF, Coughlin SR (1992) Thrombin receptor expression in normal and atherosclerotic human arteries. J Clin Invest 90:1614-1621
5. Bar-Shavit R, Benezra M, Sabbah V, Bode W, Vlodavsky I (1992) Thrombin as a multifunction protein: Induction of cell adhesion and proliferation. Am J Respir Cell Mol Biol 6:123-130
6. Chaikof EL, Caban R, Yan C-N, Rao GN, Runge MS (1995) Growth-related responses in arterial smooth muscle cells are arrested by thrombin receptor antisense sequences. J Biol Chem 270:7431-7436
7. Okazaki H, Majesky MW, Harker La, Schwartz SM (1992) Regulation of platelet-derived growth factor ligand and receptor gene expression by alpha-thrombin in vascular smooth muscle cells. Circ Res 71:1285-1293
8. Zhong C, Hayzer J, Corson MA, Runge MS (1992) Molecular cloning of the rat vascular smooth muscle thrombin receptor. Evidence for in vitro regulation by basic fibroblast growth factor. J Biol Chem 267:16975-16979
9. Coughlin SR, Vu TK, Hung DT, Wheaton VI (1992) Characterization of a functional thrombin receptor. Issues and opportunities. J Clin Invest 89:351-355
10. Sarembock IJ, Gertz SD, Gimple LW, Owen RM, Powers ER, Roberts WC (1991) Effectiveness of recombinant desulphatorhirudin in reducing restenosis after balloon angioplasty of atherosclerotic femoral arteries in rabbits. Circulation 84:232-243
11. Serruys PW, Herrman JP, Simon R, Rutsch W, Bode C, Laarman GJ, van Dijk R, van den Bos AA, Umans VA, Fox KAA, Close P, Deckers JW investigators ftH (1995) A comparison of hirudin with heparin in the prevention of restenosis after coronary angioplasty. N Engl J Med 333:757-763
12. Bode C, Hudelmayer M, Mehwald P, et al (1994) Fibrin-targeted recombinant hirudin inhibits fibrin deposition on experimental clots more efficiently than recombinant hirudin. Circulation 90:1956-1963
13. Runge MS, Schmedtje Jr JF, Horaist C, Li F, Wilcox JN, Bode C (1995) New Approaches to Inhibiting Thrombin's Effect on the Blood Vessel Wall. Fibrinolysis 9:69-73
14. Wilcox JN, Rodriguez J, Subramanian R, et al (1994) Characterization of thrombin receptor expression during vascular lesion formation. Circ Res 75:1029-1038